Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CHOP Commits $50 Million To Gene Therapy Spin-Out Spark Therapeutics

Oct 22 2013

• By Paul Bonanos

Related Content

With Precedents In Place, GenSight Eyes Gene Therapies For Orphan Disorders

Apr 08 2013

Royalty Flush: Why Monetizing Tomorrow's Revenue Stream Today Could Catch on in a Big Way

Jun 01 2008

Related Companies

Children's Hospital of Philadelphia

Royalty Pharma plc

National Institutes of Health

Avigen

Sanofi Genzyme

Astellas Gene Therapies

GenSight Biologics S.A.

Genetix Biotherapeutics

Additional Topics

Business Strategies Deals BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window